| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Oluseyi Oniyangi | Q110605842 |
| P2093 | author name string | Damian H Cohall | |
| P2860 | cites work | Phytomedicines (medicines derived from plants) for sickle cell disease | Q24186614 |
| Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease | Q24188084 | ||
| Phytomedicines (medicines derived from plants) for sickle cell disease | Q24201601 | ||
| Phytomedicines (medicines derived from plants) for sickle cell disease | Q24234577 | ||
| Malaria chemoprophylaxis in sickle cell disease | Q24244348 | ||
| Phytomedicines (medicines derived from plants) for sickle cell disease | Q24246812 | ||
| Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia | Q27024309 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Malevolent ogbanje: recurrent reincarnation or sickle cell disease? | Q28210385 | ||
| In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent | Q28213058 | ||
| Meta-analyses involving cross-over trials: methodological issues | Q29620304 | ||
| Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania | Q33831797 | ||
| Improved survival of children and adolescents with sickle cell disease | Q33839801 | ||
| The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up | Q33890227 | ||
| Evaluation of commonly used tribal and traditional remedies in Saudi Arabia | Q34501540 | ||
| Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). | Q35097294 | ||
| Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? | Q35234959 | ||
| Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study | Q35882386 | ||
| Treatment of sickle cell disorders by ayurvedic medicine | Q35901541 | ||
| Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease | Q35987429 | ||
| Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates | Q36540250 | ||
| Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. | Q36577872 | ||
| The presentation, management and prevention of crisis in sickle cell disease in Africa | Q38617805 | ||
| Hydroxyurea (hydroxycarbamide) for sickle cell disease. | Q38692796 | ||
| Medicinal plants in Mozambique and their popular use. | Q39773086 | ||
| Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. | Q40818615 | ||
| Effect of niprisan on single oral dose pharmacokinetics of paracetamol in rats. | Q42663199 | ||
| Green tea extract and aged garlic extract inhibit anion transport and sickle cell dehydration in vitro | Q43611949 | ||
| Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with Sickle Cell Disorder | Q43714655 | ||
| Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease | Q44595941 | ||
| Burden of health-care of carers of children with sickle cell disease in Nigeria | Q45060286 | ||
| Effect of cajaminose from cajanus cajan on gelation and oxygen affinity of sickle cell haemoglobin | Q46181648 | ||
| Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia | Q46395706 | ||
| The kinetics of reversal of pre-sickled erythrocytes by the aqueous extract of Cajanus cajan seeds | Q46419914 | ||
| Evaluation of Fagara zanthoxyloides root extract in sickle cell anemia blood in vitro | Q46462833 | ||
| The in vitro effects of griffonin and ouabain on erythrocyte sodium content obtained from normal subjects and sickle cell patients | Q47321289 | ||
| Malaria and sickle-cell disease | Q50238535 | ||
| Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. | Q50628739 | ||
| Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting. | Q50645895 | ||
| Effect of Zanthoxylum xanthoxyloides and some substituted benzoic acids on glucose-6-phosphate and 6-phosphogluconate dehydrogenases in Hbss red blood cells. | Q50688330 | ||
| Mortality in sickle cell disease. Life expectancy and risk factors for early death. | Q55065788 | ||
| Antisickling activity of hydroxybenzoic acids in Cajanus cajan | Q67584194 | ||
| In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes | Q73587326 | ||
| Management of patients with sickle cell disease | Q73732175 | ||
| In vitro antisickling activity of a rearranged limonoid isolated from Khaya senegalensis | Q77413183 | ||
| The reversion of sickled cells by Cajanus cajan | Q93687593 | ||
| P921 | main subject | sickle-cell disease | Q185034 |
| P304 | page(s) | CD004448 | |
| P577 | publication date | 2018-02-15 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Phytomedicines (medicines derived from plants) for sickle cell disease | |
| P478 | volume | 2 |
Search more.